AKT1 and cancer: More importantly, in multiple cancer types, S-phase-enriched lncRNAs interact with HNRNPK–YBX1 complex and affect cancer cell hallmarks through regulating phosphatidylinositol-3-kinase/AKT and MAPK signaling activation45.